Tips and tricks to cross chronic total occlusions in the superficial femoral artery

Theodosios Bisdas1, Nikolaos Patelis2, Konstantinos Stavroulakis3

  • 1Clinic of Advanced Endovascular Services, Athens Medical Center, Athens, Greece - th.bisdas@gmail.com.

Insights

Treating chronic total occlusions (CTOs) in peripheral arterial disease requires specialized skills and devices. This summary outlines key steps and techniques for successful femoropopliteal CTO recanalization.

Area of Science:

  • Vascular Medicine
  • Interventional Cardiology
  • Endovascular Surgery

Background:

  • Chronic total occlusions (CTOs) are frequently encountered in peripheral arterial disease (PAD) management.
  • Successful recanalization of CTOs is crucial for limb salvage and improving patient quality of life.
  • CTO treatment presents significant challenges requiring specialized expertise and equipment.

Purpose of the Study:

  • To summarize the essential steps for successful femoropopliteal CTO recanalization.
  • To provide practical tips on utilizing various techniques and devices for complex CTOs.
  • To emphasize the importance of adequate device inventory for PAD centers.

Main Methods:

  • Review of successful recanalization strategies for femoropopliteal CTOs.
  • Discussion of device characteristics and their application in CTO treatment.
  • Highlighting specific techniques for navigating challenging CTO lesions.

Main Results:

  • Successful recanalization depends on a combination of skilled technique and appropriate device selection.
  • Specific wires, catheters, and balloons are essential for managing complex femoropopliteal CTOs.
  • Adequate stocking of specialized devices is critical for centers managing PAD patients.

Conclusions:

  • Femoropopliteal CTO recanalization is achievable with a systematic approach.
  • Mastery of diverse techniques and devices enhances treatment success rates.
  • Centers must maintain a comprehensive inventory of endovascular tools to effectively treat PAD patients with CTOs.